Zuletzt veröffentlichtes Transkript: Reata Pharmaceuticals, Inc.
Manager | Titel | Alter | Seit |
---|---|---|---|
Director of Finance/CFO | 60 | 26.09.23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Mike Visnick
PRN | Corporate Officer/Principal | - | 01.01.07 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | - | 26.09.23 | |
Michael Dambach
BRD | Director/Board Member | - | 26.09.23 |
Robin Kramer
BRD | Director/Board Member | - | 26.09.23 |
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,10% | 0 M€ | 0.00% | - | |
0,07% | 0 M€ | 0.00% | - | |
0,05% | 735 M€ | -.--% | - | |
0,04% | 464 M€ | -.--% |
% 1. Jan. | Kap. | |
---|---|---|
+2.73% | 108 Mrd. | |
+9.59% | 103 Mrd. | |
+6.58% | 23.48 Mrd. | |
-12.59% | 21.93 Mrd. | |
-3.29% | 19.68 Mrd. | |
-35.36% | 18.37 Mrd. | |
-13.29% | 16.33 Mrd. | |
+4.68% | 13.72 Mrd. | |
+34.25% | 12.15 Mrd. |